Lipid Clinic, Oslo University Hospital

Oslo 0586

1 studies enrolling now · 3 studies all time

What they study most

Cardiovascular Disease With Mention of Arteriosclerosis, Elevated Cholesterol, Familial Hypercholesterolemia, Heterozygous Familial Hypercholesterolemia, Homozygous Familial Hypercholesterolemia

Studies at this site

• Long-term Efficacy and Safety of OLE LIB003 in HoFH, HeFH, and High-risk CVD Patients Requiring Further LDL-C Reduction — Enrolling by invitation
• Study to Assess the Efficacy and Safety of LIB003 in HeFH Patients on Oral Lipid Therapy Needing Further LDL-C Reduction — Completed
• Phase 3 Study to Evaluate the Efficacy and Safety of LIB003 With Evolocumab in HoFH — Completed